Financial News
Johnson & Johnson expects no new Covid vaccine revenue, after shots drive earnings beat
April 18, 2023 at 16:28 PM EDT
J&J's unpopular Covid vaccine appeared to bear its last fruit during the first quarter, contributing $747 million in sales.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
